We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Roger Crystal is a former ENT surgeon with more than 15 years of experience as a healthcare business executive and clinician. Dr. Crystal currently serves as Chief Executive Officer at Opiant Pharmaceuticals, a company committed to developing products for the treatment of addictions and drug overdose – one of the biggest health crises facing the country today. Opiant’s pipeline includes products for the treatment of opioid overdose, alcohol use disorder, eating disorders and opioid use disorder, including a heroin vaccine.
Dr. Crystal led the development of NARCAN® Nasal Spray, the only U.S. Food and Drug Administration-approved nasal spray for opioid overdose. He holds a BMedSci in Physiology and an MD from the University of Birmingham, UK and an MBA from the London Business School. He previously served as the Chief Business Officer for ImaginAb, a Los Angeles-based, venture capital-backed biotechnology company, leading the company’s turnaround around its immuno-oncology platform and managing its pharmaceutical company partnerships and licensing deals. He began his business career working for Goldman Sachs in Mergers and Acquisitions, as a management consultant at A.T. Kearney specializing in healthcare strategy and in business development at GE Healthcare.
Dr. Crystal is frequently featured in the media, including TV appearances, as an addiction expert. He also testified at The White House on opioid addiction and presented at the National Academies of Science.
This speaker's sessions: